LYKA LABS LTD. - 500259 - Updation Of Contact Details Of Registrar & Transfer Agent
Kindly update communication details of Registrar & Transfer Agent M/s Link Intime India Pvt Ltd as under; Name of RTA: Link Intime India Pvt Ltd Address: C-101, 247 Park, LBS Marg, Vikhroli (West), Mumbai - 400 083 Telephone: +91 22 4918 6270 Fax: +91 22 4098 6060 Email: rnt.helpdesk@linkintime.co.in Website: www.linkintime.co.in LYKA LABS LTD. - 500259 - Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations,2015 ("SEBI LODR") - Details Of Related Party Transactions
Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the disclosure under 'Related Party Transaction" on Consolidated basis for the half year ended on 30 September, 2020. We hereby request you to kindly take the above document in your records. LYKA LABS LTD. - 500259 - Un Audited Financial Results For Quarter Ended September 2020
Un Audited Financial Results for Quarter ended September 2020 LYKA LABS LTD. - 500259 - Board Meeting Intimation for Board Meeting For Consideration Of Financial Results For Second Quarter Ended September 30, 2020.
LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2020 ,inter alia, to consider and approve This is to inform you that the meeting of Board of Directors of Lyka Labs Limited is scheduled to be held on Friday, 06 November, 2020 at Corporate Office at Mumbai to consider and adopt Standalone and Consolidated Un-Audited Financial Results for the Second Quarter and Half Year ended on September 30, 2020. As informed earlier the trading window is closed from October 01, 2020 till 48 hours after declaration of Financial Results. Kindly take the same on your record. Lyka Labs Ltd - 500259 - Compliance Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosures Requirements) Regulation, 2015
In compliance with Regulation 40(9) of SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015, we enclose herewith a copy of Compliance Certificate dated 20th October, 2020 issued by Kaushal Doshi & Associates, practicing Company Secretaries for the half year ended 30th September, 2020. Lyka Labs Ltd - 500259 - Order Passed By NCLT For Approving Merger Of Lyka Healthcare Limited (Wholly Owned Subsidiary Company) With Lyka Labs Limited
We are pleased to inform you that NCLT, Ahmedabad has passed an Order dated 12th October, 2020 approving merger of Lyka Healthcare Limited with Lyka Labs Limited which was received today. Copy of the order is enclosed for your information. Kindly note the same. LYKA LABS LTD. - 500259 - Shareholding for the Period Ended September 30, 2020
Lyka Labs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here LYKA LABS LTD. - 500259 - Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (Listing Obligation And Disclosurerequirements)Regulations, 2015.
Pursuant to Regulation 7(3) of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, Please find enclosed Compliance Certificate signed by Authorized Signatory of M/s. Link lntime India Pvt. ltd, Share Transfer Agent of Lyka labs limited ("the Company") and by the Company Secretary and Compliance Officer of the Company for the half year ended 30th September,2020. LYKA LABS LTD. - 500259 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 please find enclosed Certificate for the quarter ended 30th September, 2020 received form M/s Link Intime India Pvt Ltd, Registrar and Share Transfer Agent of the Company.